These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 13220276)

  • 21. Adrenolytic and sympatholytic action of certain dihydrogenated ergot alkaloids (hydergine) on dog kidney.
    KUBICEK WG
    J Appl Physiol; 1960 Jan; 15():109-14. PubMed ID: 14412398
    [No Abstract]   [Full Text] [Related]  

  • 22. [Role of the nervous system in sympatholytic action of Claviceps purpurea alkaloids].
    FALL S; KELEMAN A; OBAL F
    Acta Physiol Acad Sci Hung; 1955; 7(3):223-7. PubMed ID: 13248576
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hydergin treatment of the tinnitus aurium in nervous hearing disorders].
    TANNER K
    Schweiz Med Wochenschr; 1955 Nov; 85(45):1100-1. PubMed ID: 13281447
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative study of some sympatholytic substances on gastric secretion].
    LI VOLSI M; PEPI S
    Riv Gastroenterol; 1953; 5(2):31-8. PubMed ID: 13075764
    [No Abstract]   [Full Text] [Related]  

  • 25. [Diagnosis of peripheral vascular disorders and their therapy with hydergin].
    OSTEN W; ZADEMACK HJ
    Arztl Wochensch; 1954 May; 9(19):437-41. PubMed ID: 13158230
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of a sympatholytic (dihydroergotamine) on uterine dynamics].
    GIBELLI GR
    Obstet Ginecol Lat Am; 1955 Aug; 13(8):327-30. PubMed ID: 13280216
    [No Abstract]   [Full Text] [Related]  

  • 27. Hydergine, a vasodilator; clinical report on hydergine in peripheral vascular disease.
    STICK WD
    Pa Med J; 1956 Sep; 59(9):1072-4. PubMed ID: 13359090
    [No Abstract]   [Full Text] [Related]  

  • 28. [Latest experience in the field of treatment of peripheral vascular diseases with intra-arterial hydergine].
    MICHELI-PELLEGRINI G; PISANI D
    Minerva Cardioangiol; 1956 Jan; 4(1):36. PubMed ID: 13321602
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical experiences with hydergine].
    STRAUSS LH
    Cardiologia (Basel); 1954; 25(1):1-36. PubMed ID: 13219632
    [No Abstract]   [Full Text] [Related]  

  • 30. Two-year results of hydergine therapy in hypertension and other circulatory disturbances.
    POLDRE A
    Acta Med Scand; 1956 Nov; 155(6):437-48. PubMed ID: 13372197
    [No Abstract]   [Full Text] [Related]  

  • 31. [Normalization of electrocardiogram and lowering of leucocytes through sympatholytic hydergin-Sandoz in pertussis].
    FRISCHKNECHT W
    Helv Paediatr Acta; 1950 May; 5(2):120-38. PubMed ID: 15421600
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapy of chronic headache with ergot alkaloids].
    KOENING F
    Praxis; 1952 Aug; 41(35):761-4. PubMed ID: 13003889
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prophylactic and symptomatic treatment of headache with ergot alkaloids].
    WASER E
    Schweiz Med Wochenschr; 1954 Oct; 84(41):1175-8. PubMed ID: 13225622
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of hydrogenated ergot alkaloids on elevated blood pressure levels.
    LABECKI TD; BRIGHT IB; GABLE GP; HAMILTON HN
    Miss Doct; 1953 Aug; 31(3):80-4. PubMed ID: 13072180
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of hypertension with dihydric alkaloids (hydergine)].
    GARAN R; ONEN KH
    Tip Fak Mecm; 1952; 15(2):740-7. PubMed ID: 13049347
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of delusions of persecution, with high agitation, by dihydrogenated ergot alkaloids].
    PICARD P; NAVARRANNE P
    Ann Med Psychol (Paris); 1955 Jun; 113 2(1):77-9. PubMed ID: 13238943
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experiences with the use of hydergin in late pregnancy toxemias].
    ALHA AL; MONTELL Y
    Duodecim; 1953; 69(3):242-6. PubMed ID: 13068287
    [No Abstract]   [Full Text] [Related]  

  • 38. [Studies on synthetic sympatholytics and oxytocis in ergotamine series].
    BOVET D
    Rend Ist Sup Sanit; 1952; 15(10):754-66. PubMed ID: 13047639
    [No Abstract]   [Full Text] [Related]  

  • 39. [Areflexia and peripheral vascular disease; therapeutic effects of hydergin].
    REWERTS G
    Med Klin; 1952 Apr; 47(14):437-9. PubMed ID: 14956553
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hypometabolism in neuroplegia].
    JAQUENOUD P; HARTUNG L; GAVEND M; MERCIER J
    Anesth Analg (Paris); 1957; 14(2):251-3. PubMed ID: 15445015
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.